SOP Guide for Pharma

Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0

Aerosol: SOP for Addressing Non-Conformance in Aerosol Manufacturing – V 2.0

SOP for Addressing Non-Conformance in Aerosol Manufacturing

Department Aerosol
SOP No. SOP/Aerosol/174/2025
Supersedes SOP/Aerosol/174/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a structured process for identifying, documenting, investigating, and addressing non-conformances in aerosol manufacturing. The goal is to ensure product quality, regulatory compliance, and continuous improvement.

2. Scope

This SOP applies to all manufacturing operations in the aerosol department, including raw material handling, formulation, filling, crimping, packaging, and final product inspection.

3. Responsibilities

  • Production Team: Responsible for identifying and reporting non-conformances during manufacturing.
  • Quality Assurance (QA) Team: Responsible for investigating non-conformances and approving corrective actions.
  • Engineering Team: Responsible for resolving equipment-related non-conformances.
  • Regulatory Affairs Team: Responsible for ensuring that non-conformance handling aligns with regulatory requirements.

4. Accountability

The QA Manager is accountable for ensuring that all non-conformances are documented, investigated, and corrective/preventive actions are implemented.

5. Procedure

5.1. Identifying Non-Conformance

  1. Non-conformances can include:
    • Product defects (e.g., incorrect fill volume, valve malfunction).
    • Process deviations (e.g., incorrect mixing time, temperature variations).
    • Equipment failures (e.g., crimping defects, pressure inconsistencies).
    • Packaging errors (e.g., mislabeling, seal integrity issues).
  2. All non-conformances must be recorded in the Non-Conformance Log (Annexure-1).

5.2. Immediate Action

  1. Quarantine the affected batch to prevent further processing.
  2. Notify the QA team and document the incident in the Immediate
Action Log (Annexure-2).
  • Identify potential safety risks and implement containment measures.
  • 5.3. Investigation and Root Cause Analysis

    1. The QA team will conduct a preliminary investigation within 24 hours.
    2. Root cause analysis should use appropriate tools:
      • 5 Whys Analysis
      • Fishbone Diagram
      • Failure Mode and Effects Analysis (FMEA)
    3. Investigation findings should be documented in the Investigation Report (Annexure-3).

    5.4. Corrective and Preventive Actions (CAPA)

    1. Based on the investigation, corrective and preventive actions should be implemented.
    2. All CAPA activities must be recorded in the CAPA Log (Annexure-4).
    3. Corrective actions may include:
      • Process adjustments.
      • Equipment maintenance or recalibration.
      • Additional training for personnel.

    5.5. Verification and Closure

    1. The QA team will verify that corrective actions have been effectively implemented.
    2. If successful, the non-conformance case is closed, and the details are recorded in the Non-Conformance Closure Log (Annexure-5).

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • FMEA: Failure Mode and Effects Analysis
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Non-Conformance Log (Annexure-1)
    2. Immediate Action Log (Annexure-2)
    3. Investigation Report (Annexure-3)
    4. CAPA Log (Annexure-4)
    5. Non-Conformance Closure Log (Annexure-5)

    8. References

    • Good Manufacturing Practice (GMP) Guidelines
    • ISO 9001 – Quality Management Systems
    • FDA Guidance on Non-Conformance Management

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Non-Conformance Log

    NC ID Issue Description Reported By Date Status
    NC-001 Incorrect fill volume Rajesh Patel 06/02/2025 Open

    Annexure-2: Immediate Action Log

    NC ID Action Taken Performed By Date
    NC-001 Batch quarantined Amit Sharma 06/02/2025

    Annexure-3: Investigation Report

    NC ID Root Cause Investigated By Date
    NC-001 Valve malfunction Ramesh Kumar 07/02/2025
    NC-002 Incorrect propellant ratio Anita Sharma 08/02/2025

    Annexure-4: CAPA Log

    NC ID Corrective Action Preventive Action Responsible Person Date
    NC-001 Replaced faulty valve Regular valve inspection Amit Sharma 08/02/2025
    NC-002 Adjusted propellant ratio Automated calibration system Rahul Mehta 09/02/2025

    Annexure-5: Non-Conformance Closure Log

    NC ID Verification Date Verified By Closure Status
    NC-001 10/02/2025 Sunil Verma Closed
    NC-002 11/02/2025 Priya Sharma Closed

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
    01/01/2025 V 2.0 Updated CAPA and verification process GMP Compliance Anjali Sharma
    Exit mobile version